ELIZABETH WU

Elizabeth Wu is a distinguished investor at Johnson & Johnson Innovation, a division dedicated to accelerating groundbreaking science and technology to address the world's most pressing health challenges. In her role, Elizabeth is instrumental in identifying, evaluating, and executing strategic investments in early stage and growth stage companies across the global healthcare landscape. Her work directly supports Johnson & Johnson's commitment to innovation, fostering a vibrant ecosystem of startups and emerging technologies.

At Johnson & Johnson Innovation, Elizabeth's investment focus spans a broad spectrum of healthcare sectors, including pharmaceuticals, medical devices, consumer health, and digital health solutions. She is particularly keen on ventures that demonstrate strong scientific merit, significant market potential, and the ability to create meaningful impact for patients and consumers. This includes novel therapeutic platforms, advanced diagnostic tools, disruptive surgical technologies, and innovative digital health solutions that enhance patient care and outcomes. Her strategic approach ensures that investments not only yield financial returns but also align with Johnson & Johnson's long term strategic objectives and therapeutic areas of interest.

Elizabeth's career background is marked by a deep understanding of both scientific innovation and financial strategy. Prior to her tenure at Johnson & Johnson Innovation, she honed her expertise through various roles in venture capital and corporate development within the life sciences sector. This experience provided her with a comprehensive perspective on the challenges and opportunities faced by emerging companies, as well as the intricate process of bringing new medical advancements to market. Her educational foundation often includes advanced degrees in scientific disciplines combined with business or finance, equipping her with the unique ability to bridge the gap between cutting edge research and commercial viability.

Through her work, Elizabeth Wu contributes significantly to the advancement of healthcare. While specific individual investments are often confidential or part of broader portfolio announcements, her efforts are directed towards supporting companies that are developing the next generation of medicines, devices, and health solutions. These investments are critical for fostering innovation, driving scientific discovery, and ultimately delivering new options to patients worldwide. Elizabeth's dedication to identifying and nurturing promising ventures underscores Johnson & Johnson Innovation's pivotal role in shaping the future of global health.